Luc Boblet
CEO of 4moving
Contact
- Email: *******@4movingbiotech.com
- Social accounts: linkedin
Companies
Company
Roles
Egle Therapeutics
Biotherapies developer targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases.
CEO
4moving
Developer of a first-in-class disease-modifying osteoarthritis drug (DMOAD) for knee osteoarthritis
CEO